Artificial intelligence assisted genomic profiling of ovarian cancer liver metastases.

Authors

Louxun Sun, Zhongshan Li, Shiming Chen

Published in

Frontiers in genetics. Volume 17. Pages 2004540. Epub Oct 20, 2026.

Abstract

Liver involvement in ovarian cancer is often treated as a single clinical entity, although liver-surface implants and parenchymal deposits occupy different anatomical settings and may not share the same molecular history. Primary-tumor profiling is informative, but can miss lesion-specific evolution, treatment-associated cell states, and microenvironmental structure. This Mini Review examines how germline susceptibility, somatic change, spatial biology, and artificial intelligence might be combined in high-grade serous ovarian cancer. The central task is not simply outcome prediction. It is to distinguish constitutional from tumor-acquired variation, retain lesion identity and treatment timing, and relate molecular programs to defined spatial compartments. Current data support marked clonal and microenvironmental heterogeneity in ovarian cancer, but direct molecular evidence from hepatic lesions remains sparse. AI-based integration is therefore best viewed as a way to formulate and test reproducible hypotheses, rather than as a validated route to select liver-directed therapy. Paired sampling, orthogonal assays, patient-level validation, and decision-specific clinical endpoints will be needed before these models can influence management.

PMID:
42974638
Bibliographic data and abstract were imported from PubMed on 03 Nov 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.